Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Glioblastoma 31Gliosarcoma 27Astrocytoma 22Brain Neoplasms 17Central Nervous System Neoplasms 16Oligodendroglioma 12Medulloblastoma 9Neuroblastoma 7Glioma 7Choroid Plexus Neoplasms 7Sarcoma 6Melanoma 6Familial ependymoma 6Optic Nerve Glioma 5Spinal Cord Neoplasms 4Rhabdoid Tumor 4Neuroectodermal Tumors, Primitive, Peripheral 4Ependymoma 4Uveal Melanoma 3Rhabdomyosarcoma 3Ovarian Neoplasms 3Osteosarcoma 3Neuroectodermal Tumors, Primitive 3Breast Neoplasms 3Wilms Tumor 2Testicular Neoplasms 2Teratoma 2Small Cell Lung Carcinoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pinealoma 2

Interventions

fludarabine phosphate 8Cytarabine 8Peripheral Blood Stem Cell Transplantation 7Imatinib Mesylate 5Cyclophosphamide 5Busulfan 5Vorinostat 4Filgrastim 4Etoposide 4Antilymphocyte Serum 4tipifarnib 3sargramostim 3Sorafenib 3Radiotherapy 3Methylprednisolone 3Methotrexate 3Ifosfamide 3Decitabine 3Cyclosporine 3Bortezomib 33-aminopyridine-2-carboxaldehyde thiosemicarbazone 3temsirolimus 2laromustine 2belinostat 2alvocidib 2Vincristine 2Sirolimus 2Mycophenolic Acid 2Interferon-alpha 2Idarubicin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Blast Crisis × Temozolomide × Clear all
NCT00098436 2013-07-18

Temozolomide and VNP40101M in Treating Patients With Relapsed or Refractory Leukemias

National Cancer Institute (NCI)

Phase 1 Completed
25 enrolled
LymphoidOther hematologic neoplasm

Congenital Abnormalities, Blast Crisis, Leukemia, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡